RAD6 promotes DNA repair and stem cell signaling in ovarian cancer and is a promising therapeutic target to prevent and treat acquired chemoresistance
出版年份 2017 全文链接
标题
RAD6 promotes DNA repair and stem cell signaling in ovarian cancer and is a promising therapeutic target to prevent and treat acquired chemoresistance
作者
关键词
-
出版物
ONCOGENE
Volume 36, Issue 48, Pages 6680-6690
出版商
Springer Nature
发表日期
2017-08-14
DOI
10.1038/onc.2017.279
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Monoubiquitylation of histone H2B contributes to the bypass of DNA damage during and after DNA replication
- (2017) Shih-Hsun Hung et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Rad6 upregulation promotes stem cell-like characteristics and platinum resistance in ovarian cancer
- (2016) Ranganatha R. Somasagara et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Synthesis and in vitro anticancer evaluation of some 4,6-diamino-1,3,5-triazine-2-carbohydrazides as Rad6 ubiquitin conjugating enzyme inhibitors
- (2016) Hend Kothayer et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Gold nanoparticle conjugated Rad6 inhibitor induces cell death in triple negative breast cancer cells by inducing mitochondrial dysfunction and PARP-1 hyperactivation: Synthesis and characterization
- (2016) Brittany Haynes et al. Nanomedicine-Nanotechnology Biology and Medicine
- Establishment and Characterization of an In Vitro Model of Ovarian Cancer Stem-like Cells with an Enhanced Proliferative Capacity
- (2015) T. Ishiguro et al. CANCER RESEARCH
- Cancer stem cells: a challenging paradigm for designing targeted drug therapies
- (2015) Ishaq N. Khan et al. DRUG DISCOVERY TODAY
- FANCJ protein is important for the stability of FANCD2/FANCI proteins and protects them from proteasome and caspase-3 dependent degradation
- (2015) David W. Clark et al. Oncotarget
- Molecular Requirements for Transformation of Fallopian Tube Epithelial Cells into Serous Carcinoma
- (2015) Amir A. Jazaeri et al. NEOPLASIA
- “Platinum resistant” ovarian cancer: What is it, who to treat and how to measure benefit?
- (2014) Alison Davis et al. GYNECOLOGIC ONCOLOGY
- Gli1 Protein Regulates the S-phase Checkpoint in Tumor Cells via Bid Protein, and Its Inhibition Sensitizes to DNA Topoisomerase 1 Inhibitors
- (2014) Kaushlendra Tripathi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Rad18 and Rnf8 facilitate homologous recombination by two distinct mechanisms, promoting Rad51 focus formation and suppressing the toxic effect of nonhomologous end joining
- (2014) S Kobayashi et al. ONCOGENE
- β-Catenin-regulated ALDH1A1 is a target in ovarian cancer spheroids
- (2014) S Condello et al. ONCOGENE
- ALDH1A1 Maintains Ovarian Cancer Stem Cell-Like Properties by Altered Regulation of Cell Cycle Checkpoint and DNA Repair Network Signaling
- (2014) Erhong Meng et al. PLoS One
- Wnt/Catenin Signaling in Adult Stem Cell Physiology and Disease
- (2014) Alexander Ring et al. Stem Cell Reviews and Reports
- Optimised synthesis of diamino-triazinylmethyl benzoates as inhibitors of Rad6B ubiquitin conjugating enzyme
- (2014) Hend Kothayer et al. TETRAHEDRON LETTERS
- Rad6 is a Potential Early Marker of Melanoma Development
- (2014) Karli Rosner et al. Translational Oncology
- Design, synthesis and in vitro anticancer evaluation of 4,6-diamino-1,3,5-triazine-2-carbohydrazides and -carboxamides
- (2013) Hend Kothayer et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A small ubiquitin binding domain inhibits ubiquitin-dependent protein recruitment to DNA repair foci
- (2013) Corey Helchowski et al. CELL CYCLE
- USP49 deubiquitinates histone H2B and regulates cotranscriptional pre-mRNA splicing
- (2013) Z. Zhang et al. GENES & DEVELOPMENT
- Novel Inhibitors of Rad6 Ubiquitin Conjugating Enzyme: Design, Synthesis, Identification, and Functional Characterization
- (2013) M. A. Sanders et al. MOLECULAR CANCER THERAPEUTICS
- Histone Crosstalk: H2Bub and H3K4 Methylation
- (2013) Luis M. Soares et al. MOLECULAR CELL
- On the role of Wnt/β-catenin signaling in stem cells
- (2012) Susanne J. Kühl et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Lysine 394 is a novel Rad6B-induced ubiquitination site on beta-catenin
- (2012) Brigitte Gerard et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Histone H2B lysine 120 monoubiquitination is required for embryonic stem cell differentiation
- (2012) Su Chen et al. CELL RESEARCH
- Shaping the landscape: mechanistic consequences of ubiquitin modification of chromatin
- (2012) Sigurd Braun et al. EMBO REPORTS
- Rad18 E3 ubiquitin ligase activity mediates Fanconi anemia pathway activation and cell survival following DNA Topoisomerase 1 inhibition
- (2011) Komaraiah Palle et al. CELL CYCLE
- The diverse functions of Dot1 and H3K79 methylation
- (2011) A. T. Nguyen et al. GENES & DEVELOPMENT
- WAC, a Functional Partner of RNF20/40, Regulates Histone H2B Ubiquitination and Gene Transcription
- (2011) Feng Zhang et al. MOLECULAR CELL
- Wnt/β-catenin Signaling in Embryonic Stem Cell Self-renewal and Somatic Cell Reprogramming
- (2011) Toshio Miki et al. Stem Cell Reviews and Reports
- Histone H2B ubiquitination and beyond
- (2010) Mahesh B. Chandrasekharan et al. Epigenetics
- RAD18-mediated ubiquitination of PCNA activates the Fanconi anemia DNA repair network
- (2010) Liyi Geng et al. JOURNAL OF CELL BIOLOGY
- Immunotherapy for Ovarian Cancer: What's Next?
- (2010) Lana E. Kandalaft et al. JOURNAL OF CLINICAL ONCOLOGY
- RAD6-Mediated Transcription-Coupled H2B Ubiquitylation Directly Stimulates H3K4 Methylation in Human Cells
- (2009) Jaehoon Kim et al. CELL
- Rad6B Is a Positive Regulator of -Catenin Stabilization
- (2008) M. P.V. Shekhar et al. CANCER RESEARCH
- A Genome-Wide Screen for -Catenin Binding Sites Identifies a Downstream Enhancer Element That Controls c-Myc Gene Expression
- (2008) G. S. Yochum et al. MOLECULAR AND CELLULAR BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More